Archer Materials Advances Miniaturized Biochip Technology
Company Announcements

Archer Materials Advances Miniaturized Biochip Technology

Archer Materials Limited (AU:AXE) has released an update.

Archer Materials Limited has successfully miniaturized its Biochip graphene field effect transistor (gFET) design, reducing its size by 97% and significantly lowering fabrication costs. This advancement, achieved in collaboration with Applied Nanolayers and AOI Electronics, enhances the chip’s readiness for integration in home testing devices for chronic kidney disease. The development marks a significant step in Archer’s efforts to strengthen its semiconductor capabilities and expand its role in medical diagnostics.

For further insights into AU:AXE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskArcher Materials Advances Quantum Project with New Device
TipRanks Australian Auto-Generated NewsdeskArcher Materials Innovates with Quantum Devices and Sensors
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App